Top

Published in:

01-06-2011 | NON-THEMATIC REVIEW

The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations

Authors: Michal R. Schweiger, Martin Kerick, Bernd Timmermann, Melanie Isau

Published in: Cancer and Metastasis Reviews | Issue 2/2011

Abstract

The development of cancer is characterized by the joined occurrence of alterations on different levels—from single nucleotide changes via structural and copy number variations to epigenetic alterations. With the advent of advanced technologies such as next generation sequencing, we have now the tools in hands to put some light on complex processes and recognize systematic patterns that develop throughout cancer progression. The combination of single hypothesis-driven experiments with a system-wide genetic view enables us to prove so far not addressable questions such as the influence of DNA methylation on gene expression or the disruption of genome homeostasis by structural variations and miRNA expression patterns. Out of this enormous amount of information, specific biomarkers for cancer progression have been discovered, which pave the way for the development of new therapeutic strategies. Here, we will review the status quo of integrative cancer genomic approaches, give an overview over the power of next generation sequencing technologies in oncology, and outline future perspective. Both sides—clinical as well as basic research aspects—will be considered.

Krawitz, P. M., Schweiger, M. R., Rodelsperger, C., Marcelis, C., Kolsch, U., et al. (2010). Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nature Genetics, 42, 827–829.PubMedCrossRef

Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272–276.PubMedCrossRef

Bagnyukova, T., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., et al. (2010). Chemotherapy and signaling: how can targeted therapies supercharge cytotoxic agents? Cancer Biol Ther, 10(9), 839–853.PubMedCrossRef

Branton, D., Deamer, D. W., Marziali, A., Bayley, H., Benner, S. A., et al. (2008). The potential and challenges of nanopore sequencing. Nature Biotechnology, 26, 1146–1153.PubMedCrossRef

Pleasance, E. D., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A., et al. (2010). A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature, 463, 184–190.PubMedCrossRef

Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., et al. (2010). A comprehensive catalogue of somatic mutations from a human cancer genome. Nature, 463, 191–196.PubMedCrossRef

Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., et al. (2008). DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature, 456, 66–72.PubMedCrossRef

Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., et al. (2009). Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature, 461, 809–813.PubMedCrossRef

Gilbert, M. T., Haselkorn, T., Bunce, M., Sanchez, J. J., Lucas, S. B., et al. (2007). The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS ONE, 2, e537.PubMedCrossRef

10.

Schweiger, M. R., Kerick, M., Timmermann, B., Albrecht, M. W., Borodina, T., et al. (2009). Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS ONE, 4, e5548.PubMedCrossRef

11.

Bian, Y. S., Yan, P., Osterheld, M. C., Fontolliet, C., & Benhattar, J. (2001). Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP. Biotechniques, 30, 66–72.PubMed

12.

Chiu, R. W., Chan, K. C., Gao, Y., Lau, V. Y., Zheng, W., et al. (2008). Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America, 105, 20458–20463.PubMedCrossRef

13.

Kerjean, A., Vieillefond, A., Thiounn, N., Sibony, M., Jeanpierre, M., et al. (2001). Bisulfite genomic sequencing of microdissected cells. Nucleic Acids Research, 29, E106–106.PubMedCrossRef

14.

Fan, H. C., Blumenfeld, Y. J., Chitkara, U., Hudgins, L., & Quake, S. R. (2008). Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proceedings of the National Academy of Sciences of the United States of America, 105, 16266–16271.PubMedCrossRef

15.

van der Vaart, M., Semenov, D. V., Kuligina, E. V., Richter, V. A., & Pretorius, P. J. (2009). Characterisation of circulating DNA by parallel tagged sequencing on the 454 platform. Clinica Chimica Acta, 409, 21–27.CrossRef

16.

Beck, J., Urnovitz, H. B., Mitchell, W. M., & Schutz, E. (2010). Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Molecular Cancer Research, 8, 335–342.PubMedCrossRef

17.

McBride, D. J., Orpana, A. K., Sotiriou, C., Joensuu, H., Stephens, P. J., et al. (2010). Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes, Chromosomes & Cancer, 49, 1062–1069.CrossRef

18.

Maxam, A. M., & Gilbert, W. (1977). A new method for sequencing DNA. Proceedings of the National Academy of Sciences of the United States of America, 74, 560–564.PubMedCrossRef

19.

Sanger, F., Nicklen, S., & Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 74, 5463–5467.PubMedCrossRef

20.

The International Human Genome Sequencing Consortium (2004). Finishing the euchromatic sequence of the human genome. Nature, 431, 931–945.CrossRef

21.

Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.PubMedCrossRef

22.

Mardis, E. R. (2008). Next-generation DNA sequencing methods. Annual Review of Genomics and Human Genetics, 9, 387–402.PubMedCrossRef

23.

Shendure, J., & Ji, H. (2008). Next-generation DNA sequencing. Nature Biotechnology, 26, 1135–1145.PubMedCrossRef

24.

Metzker, M. L. (2010). Sequencing technologies—the next generation. Nature Reviews. Genetics, 11, 31–46.PubMedCrossRef

25.

Ding, L., Wendl, M. C., Koboldt, D. C., & Mardis, E. R. (2010). Analysis of next-generation genomic data in cancer: accomplishments and challenges. Human Molecular Genetics, 19, R188–R196.PubMedCrossRef

26.

Meyerson, M., Gabriel, S., & Getz, G. (2010). Advances in understanding cancer genomes through second-generation sequencing. Nature Reviews. Genetics, 11, 685–696.PubMedCrossRef

27.

Rothberg, J. M., & Leamon, J. H. (2008). The development and impact of 454 sequencing. Nature Biotechnology, 26, 1117–1124.PubMedCrossRef

28.

Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., et al. (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437, 376–380.PubMed

29.

Ronaghi, M. (2001). Pyrosequencing sheds light on DNA sequencing. Genome Research, 11, 3–11.PubMedCrossRef

30.

Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., et al. (2008). Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456, 53–59.PubMedCrossRef

31.

Shendure, J., Porreca, G. J., Reppas, N. B., Lin, X., McCutcheon, J. P., et al. (2005). Accurate multiplex polony sequencing of an evolved bacterial genome. Science, 309, 1728–1732.PubMedCrossRef

32.

Blow, N. (2008). DNA sequencing: generation next-next. Nat Methods, 5(6), 267–274.CrossRef

33.

Clarke, J., Wu, H. C., Jayasinghe, L., Patel, A., Reid, S., et al. (2009). Continuous base identification for single-molecule nanopore DNA sequencing. Nature Nanotechnology, 4, 265–270.PubMedCrossRef

34.

Greenleaf, W. J., & Block, S. M. (2006). Single-molecule, motion-based DNA sequencing using RNA polymerase. Science, 313, 801.PubMedCrossRef

35.

Sugiyama, S. (2006). Application of scanning probe microscopy to genetic analysis. Japanese journal of applied physics, 45, 4.CrossRef

36.

Pourmand, N., Karhanek, M., Persson, H. H., Webb, C. D., Lee, T. H., et al. (2006). Direct electrical detection of DNA synthesis. Proceedings of the National Academy of Sciences of the United States of America, 103, 6466–6470.PubMedCrossRef

37.

Albert, T. J., Molla, M. N., Muzny, D. M., Nazareth, L., Wheeler, D., et al. (2007). Direct selection of human genomic loci by microarray hybridization. Nat Methods, 4, 903–905.PubMedCrossRef

38.

Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 19096–19101.PubMedCrossRef

39.

Gnirke, A., Melnikov, A., Maguire, J., Rogov, P., LeProust, E. M., et al. (2009). Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nature Biotechnology, 27, 182–189.PubMedCrossRef

40.

Hodges, E., Xuan, Z., Balija, V., Kramer, M., Molla, M. N., et al. (2007). Genome-wide in situ exon capture for selective resequencing. Nature Genetics, 39, 1522–1527.PubMedCrossRef

41.

Porreca, G. J., Zhang, K., Li, J. B., Xie, B., Austin, D., et al. (2007). Multiplex amplification of large sets of human exons. Nat Methods, 4, 931–936.PubMedCrossRef

42.

The Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061–1068.CrossRef

43.

Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., et al. (2003). Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 300, 949.PubMedCrossRef

44.

Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., et al. (2007). Patterns of somatic mutation in human cancer genomes. Nature, 446, 153–158.PubMedCrossRef

45.

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C., Leary, R. J., et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801–1806.PubMedCrossRef

46.

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807–1812.PubMedCrossRef

47.

Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268–274.PubMedCrossRef

48.

Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science, 318, 1108–1113.PubMedCrossRef

49.

Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., et al. (2009). Recurring mutations found by sequencing an acute myeloid leukemia genome. The New England Journal of Medicine, 361, 1058–1066.PubMedCrossRef

50.

Fredman, D., White, S. J., Potter, S., Eichler, E. E., Den Dunnen, J. T., et al. (2004). Complex SNP-related sequence variation in segmental genome duplications. Nature Genetics, 36, 861–866.PubMedCrossRef

51.

Druker, B. J. (2008). Translation of the Philadelphia chromosome into therapy for CML. Blood, 112, 4808–4817.PubMedCrossRef

52.

Park, J. W., Neve, R. M., Szollosi, J., & Benz, C. C. (2008). Unraveling the biologic and clinical complexities of HER2. Clinical Breast Cancer, 8, 392–401.PubMedCrossRef

53.

Campbell, P. J., Stephens, P. J., Pleasance, E. D., O’Meara, S., Li, H., et al. (2008). Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genetics, 40, 722–729.PubMedCrossRef

54.

Stephens, P. J., McBride, D. J., Lin, M. L., Varela, I., Pleasance, E. D., et al. (2009). Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature, 462, 1005–1010.PubMedCrossRef

55.

Beck, S., & Rakyan, V. K. (2008). The methylome: approaches for global DNA methylation profiling. Trends in Genetics, 24, 231–237.PubMedCrossRef

56.

Feinberg, A. P. (2007). Phenotypic plasticity and the epigenetics of human disease. Nature, 447, 433–440.PubMedCrossRef

57.

Banerjee, H. N., & Verma, M. (2009). Epigenetic mechanisms in cancer. Biomarkers Medicine, 3, 14.

58.

Lister, R., & Ecker, J. R. (2009). Finding the fifth base: genome-wide sequencing of cytosine methylation. Genome Research, 19, 959–966.PubMedCrossRef

59.

Ball, M. P., Li, J. B., Gao, Y., Lee, J. H., LeProust, E. M., et al. (2009). Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nature Biotechnology, 27, 361–368.PubMedCrossRef

60.

Rakyan, V. K., Down, T. A., Thorne, N. P., Flicek, P., Kulesha, E., et al. (2008). An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Research, 18, 1518–1529.PubMedCrossRef

61.

Morozova, O., Hirst, M., & Marra, M. A. (2009). Applications of new sequencing technologies for transcriptome analysis. Annual Review of Genomics and Human Genetics, 10, 135–151.PubMedCrossRef

62.

Sultan, M., Schulz, M. H., Richard, H., Magen, A., Klingenhoff, A., et al. (2008). A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science, 321, 956–960.PubMedCrossRef

63.

Friedel, C. C., & Dolken, L. (2009). Metabolic tagging and purification of nascent RNA: implications for transcriptomics. Molecular Biosystems, 5, 1271–1278.PubMedCrossRef

64.

Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews. Cancer, 9, 302–312.PubMedCrossRef

65.

Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., et al. (2010). The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature, 467, 1109–1113.PubMedCrossRef

66.

Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., et al. (2010). Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature, 464, 999–1005.PubMedCrossRef

Title: The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations
Authors: Michal R. Schweiger
Martin Kerick
Bernd Timmermann
Melanie Isau
Publication date: 01-06-2011
Publisher: Springer US
Published in: Cancer and Metastasis Reviews / Issue 2/2011
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-011-9278-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Microbial deprivation, inflammation and cancer

The role of nuclear pore complex in tumor microenvironment and metastasis

True local recurrences do not metastasize

The heparanase system and tumor metastasis: is heparanase the seed and soil?

External validation of a model to predict the survival of patients presenting with a spinal epidural metastasis

Erratum to: Myeloid cell diversification and complexity: an old concept with new turns in oncology

Keynote webinar | Spotlight on antibody–drug conjugates in cancer